Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Genomic Uniformed-Screening Against Rare Disease In All Newborns | Clinical Trials | Clareo Health

Back to search

RECRUITINGNA

Genomic Uniformed-Screening Against Rare Disease In All Newborns

NCT05990179•Columbia University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Early Onset Genetic Conditions With Near Complete Penetrance

Interventions

Genome sequencing-based newborn screening

Locations

United States

Locations (1)

Columbia University Irving Medical Center/NYP

New York, New York, United States

Key Dates

Start Date

September 6, 2022

Primary Completion Date

September 1, 2029

Completion Date

September 1, 2029

Last Updated

September 19, 2025

Contacts

Anah Hetzler

CONTACT

212-305-5508 ak3578@cumc.columbia.edu

Sponsors

Lead Sponsor

Columbia University

Collaborators

Illumina, Inc.
GeneDx
New York State Department of Health

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions